RVMD - Revolution Medicines, Inc.


101.19
0.700   0.692%

Share volume: 1,561,782
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$100.49
0.70
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-07-2024 11-06-2024 02-26-2025 05-07-2025 11-05-2025 02-25-2026
Total revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 0.000 0.000 0.000 0.000 0.000 0.000 0.000
    nan% nan% nan%   nan% nan%  
Operating expenses 140.859 M 156.643 M 175.712 M 216.310 M 240.760 M 315.269 M 361.626 M
Selling general and admin 22.838 M 21.711 M 23.960 M 28.790 M 35.011 M 52.763 M 66.683 M
Research and development 118.021 M 134.932 M 151.752 M 187.520 M 205.749 M 262.506 M 294.943 M
Total expenses 140.859 M 156.643 M 175.712 M 216.310 M 240.760 M 315.269 M 361.626 M
    11.21% 12.17% 23.10% 11.30% 30.95% 14.70%  
Operating income -140.859 M -156.643 M -175.712 M -216.310 M -240.760 M -315.269 M -361.626 M
Ebit -140.859 M -154.720 M -175.430 M -222.139 M -238.331 M -315.861 M -374.280 M
Pretax income -116.003 M -133.233 M -156.288 M -195.322 M -213.416 M -305.206 M -364.892 M
    14.85% 17.30% 24.98% 9.26% 43.01% 19.56%  
Income tax 0.000 0.000 0.000 -753.000 K 0.000 0.000 0.000
Net income basic -116.003 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -116.003 M -133.233 M -156.288 M -194.569 M -213.416 M -305.206 M -364.892 M
    -14.85% -17.30% -24.49% -9.69% -43.01% -19.56%